Sanofi Heart Drug Multaq Linked To Liver Failure
The U.S. Food and Drug Administration warned Friday that Multaq, Sanofi-Aventis SA's 18-month-old drug for heart problems, may be linked to liver damage in some patients, including two women whose livers...To view the full article, register now.
Already a subscriber? Click here to view full article